levobunolol hydrochloride 5 MG/ML Ophthalmic Solution
levobunolol hydrochloride
RxCUI: 1150836
What the CMS Formulary Data Shows for levobunolol hydrochloride 5 MG/ML Ophthalmic Solution
Per the CMS 2026 Part D formulary file, levobunolol hydrochloride 5 MG/ML Ophthalmic Solution (RxNorm concept RXCUI 1150836, generic name levobunolol hydrochloride) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 1.6.
Real-world access to levobunolol hydrochloride 5 MG/ML Ophthalmic Solution depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0.6% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 13,542 Part D beneficiaries filled levobunolol hydrochloride 5 MG/ML Ophthalmic Solution in 2023, with total plan-and-beneficiary spending of $1,515,148 and an average per-beneficiary annual cost of $111.89. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry levobunolol hydrochloride 5 MG/ML Ophthalmic Solution today.
Coverage Details
- Formularies covering
- 330
- Plans covering
- 5,067
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0.6% of formularies
2023 Medicare Spending
- Beneficiaries
- 13,542
- Total spending
- $1,515,148
- Avg per beneficiary
- $111.89
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering levobunolol hydrochloride 5 MG/ML Ophthalmic Solution
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering levobunolol hydrochloride 5 MG/ML Ophthalmic Solution
98 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is levobunolol hydrochloride 5 MG/ML Ophthalmic Solution covered by Medicare Part D?
Yes, levobunolol hydrochloride 5 MG/ML Ophthalmic Solution is covered by 5,067 Medicare Part D plans (100% of all Part D formularies).
What tier is levobunolol hydrochloride 5 MG/ML Ophthalmic Solution on Medicare Part D plans?
levobunolol hydrochloride 5 MG/ML Ophthalmic Solution averages Tier 1.6 across Part D plans, ranging from Tier 1 to Tier 4.
Does levobunolol hydrochloride 5 MG/ML Ophthalmic Solution require prior authorization?
0% of Part D formularies require prior authorization for levobunolol hydrochloride 5 MG/ML Ophthalmic Solution. Step therapy: 0%. Quantity limits: 0.6%.
How much does Medicare spend on levobunolol hydrochloride 5 MG/ML Ophthalmic Solution?
In 2023, total Medicare Part D spending on levobunolol hydrochloride 5 MG/ML Ophthalmic Solution was $1,515,148, covering 13,542 beneficiaries. The average spend per beneficiary was $111.89.
Read our methodology - how this data is sourced, computed, and verified.